Health Care & Life Sciences » Pharmaceuticals | Henan Taloph Pharmaceutical Stock Co. Ltd.

Henan Taloph Pharmaceutical Stock Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,300
1,250
1,014
945
1,159
1,184
Cost of Goods Sold (COGS) incl. D&A
1,075
1,020
812
682
848
837
Gross Income
225
229
202
263
311
347
SG&A Expense
114
118
146
189
239
282
EBIT
106
107
50
75
72
63
Unusual Expense
-
-
-
6
12
129
Non Operating Income/Expense
1
1
1
4
5
2
Interest Expense
45
52
65
65
57
58
Pretax Income
67
65
8
11
11
116
Income Tax
15
15
12
9
3
-
Equity in Affiliates
-
-
1
-
-
1
Consolidated Net Income
52
50
4
2
7
115
Net Income
36
32
6
4
5
115
Net Income After Extraordinaries
36
32
6
4
5
115
Net Income Available to Common
36
32
6
4
5
115
EPS (Basic)
0.08
0.06
0.01
0.01
0.01
0.20
Basic Shares Outstanding
447
497
556
574
574
574
EPS (Diluted)
0.08
0.06
0.01
0.01
0.01
0.20
Diluted Shares Outstanding
447
497
556
574
574
574
EBITDA
147
151
102
133
128
119
Other Operating Expense
5
5
6
1
-
2
Non-Operating Interest Income
3
8
4
3
3
7
Minority Interest Expense
16
18
1
2
2
-

About Henan Taloph Pharmaceutical Stock Co.

View Profile
Address
No. 8 Jinsuo Road
Zhengzhou Henan 450001
China
Employees -
Website http://www.taloph.com
Updated 07/08/2019
Henan Taloph Pharmaceutical Stock Co., Ltd. engages in the pharmaceutical manufacturing, management, and scientific research of Chinese and western medicine products. . Its business is divided into four segments: Chinese medicine oral solution pharmaceutical preparation business, Chinese herbal oral and tablets business, pharmaceutical research and development technical services, and medical business.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.